Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VRML - Vermillion Inc.

Previous close
4
4.000   100.000%

Share volume: 0
Last Updated: Thu 11 Jun 2020 10:00:00 PM CEST
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
12%
Profitability 9%
Dept financing 29%
Liquidity 33%
Performance 5%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$4.00
P/E Ratio 
N/A
DAY RANGE
$4.00 - $4.00
EPS 
-$0.17
52 WEEK RANGE
$0.35 - $5.78
52 WEEK CHANGE
$263.64
MARKET CAP 
389.512 M
YIELD 
N/A
SHARES OUTSTANDING 
97.378 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$50,632,029
AVERAGE 10 VOLUME 
$2,536,546
AVERAGE 30 VOLUME 
$1,184,118
Company detail
CEO: Valerie Barber Palmieri
Region: US
Website: http://www.vermillion.com
Employees: 53
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Recent news